EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular Basis of Cardiomyopathies in Type 2 Diabetes

Silvia Giardinelli, Giovanni Meliota iD, Donatella Mentino iD, Gabriele D'Amato, Maria Felicia Faienza iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25158280 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Silvia Giardinelli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Pediatrics, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Cardiomyopathies, Oxidative Stress. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic cardiomyopathy (DbCM) is a common complication in individuals with type 2 diabetes mellitus (T2DM), and its exact pathogenesis is still debated. It was hypothesized that chronic hyperglycemia and insulin resistance activate critical cellular pathways that are responsible for numerous functional and anatomical perturbations in the heart. Interstitial inflammation, oxidative stress, myocardial apoptosis, mitochondria dysfunction, defective cardiac metabolism, cardiac remodeling, hypertrophy and fibrosis with consequent impaired contractility are the most common mechanisms implicated. Epigenetic changes also have an emerging role in the regulation of these crucial pathways. The aim of this review was to highlight the increasing knowledge on the molecular mechanisms of DbCM and the new therapies targeting specific pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetic CardiomyopathiesOxidative StressHumansAnimalsInsulin ResistanceEpigenesis, GeneticMyocardiumApoptosis

Stichwörter der Autor:innen

Glucagon-like Peptide-1 (GLP-1) receptor agonistscardiac remodelingdiabetic cardiomyopathyepigeneticsgliflozinsheart failuremolecular mechanismstherapeutic approachestype 2 diabetes

Autor:innen und Institutionen

  • Department of Medical Sciences, Pediatrics, University of Ferrara, 44121 Ferrara, Italy.
  • Department of Pediatric Cardiology, Giovanni XXIII Pediatric Hospital, 70126 Bari, Italy.
  • Pediatric Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro", 70124 Bari, Italy.
  • Neonatal Intensive Care Unit, Di Venere Hospital, 70012 Bari, Italy.

ORCID-Profile: Giovanni Meliota, Donatella Mentino, Maria Felicia Faienza

Zitieren

APA

Giardinelli, S., Meliota, G., Mentino, D., D'Amato, G., & Faienza, M. F. (2024). Molecular Basis of Cardiomyopathies in Type 2 Diabetes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158280

Vancouver

Giardinelli S, Meliota G, Mentino D, D'Amato G, Faienza MF. Molecular Basis of Cardiomyopathies in Type 2 Diabetes. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158280

BibTeX
@article{Giardinelli2024,
  author = {Giardinelli, Silvia and Meliota, Giovanni and Mentino, Donatella and D'Amato, Gabriele and Faienza, Maria Felicia},
  title = {Molecular Basis of Cardiomyopathies in Type 2 Diabetes},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25158280}
}
Kostenlos starten →